Want to see ADCT full AI Analyst Report?
ADC Therapeutics (ADCT) Revenue
ADC Therapeutics Revenue
ADC Therapeutics had a revenue of 19.25M in the quarter ending Jun 30, 2026, with -3.92%. This bring the company's revenue in the last twelve months to 78.77M, Increased 0.52%. In the fiscal year ending Dec 31, 2025, ADC Therapeutics had annual revenue of 81.36M with 14.85% growth.
- Revenue (ttm)
- 78.77M
- Revenue Growth
- 3.03%
- P/S Ratio
- 2.40
- Revenue/Employee
- $425,953
- Employees
- 191
- Market Cap
- $195.33M
Revenue Chart
ADC Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.36M | 10.52M | 14.85% |
| Dec 31, 2024 | 70.84M | 1.28M | 1.84% |
| Dec 31, 2023 | 69.56M | -140.35M | -66.86% |
| Dec 31, 2022 | 209.91M | 175.99M | 518.89% |
| Dec 31, 2021 | 33.92M | 33.92M | ― |
| Dec 31, 2020 | 0.00 | -2.34M | -100.00% |
| Dec 31, 2019 | 2.34M | 1.20M | 105.26% |
| Dec 31, 2018 | 1.14M | -663.00K | -36.77% |
| Dec 31, 2017 | 1.80M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.